Clinical Trial Search

Primary: Change From Baseline in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) Subscore at Week 8 or Last Observation Carried Forward (LOCF)…

Primary: Relative Percent Change From Baseline in Mean Lumbar Spine Bone Mineral Density (BMD) at 12, 24 and 36 Months — 0.7969; 0.7861; 0.8378; 0.8845 Percent change

Primary: Change From Baseline in Mean Seated Trough Cuff Systolic Blood Pressure (SBP) to Week 7 — -28.5; -37.0 mmHg — p=<0.0001

Primary: Renal Function (Nankivell Formula) at Month 12 Post Transplantation. — 71.84; 61.24 mL/min /1.73m^2

Primary: The Mean Change From Baseline to Week 20 in the Overall Asthma Quality of Life Questionnaire (AQLQ) — 3.1; 3.1; 4.4; 3.0 Units on a scale

Primary: Change From Baseline in Calculated Creatinine Clearance (Cockcroft-Gault Equation) at 52 Weeks Post-randomization — -1.35; 3.03 mL/min/1.73m^2 — p=0.004

Primary: Number of Participants With Virologic Response (VR) — 46; 50; 29; 27 participants — p=0.7142

Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) — -28.82; -26.22 mmHg

Primary: Number of Participants With Glycemic Control (Glucose Levels Between 180-300 mg/dL) 24 to 100 Hours After Line Change — 17; 16 Participants — p=0.52

Primary: Incidence of Gastroduodenal Ulcers — 1.4; 27.6; 2.7 Percent — p=<0.0001

Primary: Change in Total Cholesterol (TC), High Density Lipoprotein-Cholesterol (HDL-C), Low Density Lipoprotein-Cholesterol (LDL-C) and Triglycerides (TG) Levels From Baseline…

Primary: First Occurrence of (Moderate or Severe) COPD Exacerbation — 1277; 1414 number of first occurrences — p=<0.0001

Primary: Target Lesion Failure — 8.2; 8.3 percentage of participants

Primary: Number of Participants With Systemic Allergic Reactions (SAR) to Specific Immunotherapy (SIT) — 32; 17; 49 participants

Primary: Numbers of Patients With First Occurence of Stroke — 82; 119 participants — p=0.0357